Pioneering Medical Innovations
The FDA granted 510(k) clearance for the Zoom 7X Catheter, the first catheter featuring CenTRX Technology for enhanced navigation and asymmetric clot ingestion, with first patient cases completed.
A late-breaking abstract at the SNIS 2025 annual meeting reported strong reperfusion and safety results with the Zoom System in stroke patients with M2 vessel occlusions.
Veteran medtech executive Raymond W. Cohen was appointed Vice Chairman of Tulavi Therapeutics’ Board of Directors.
Tyler Binney joined Imperative Care’s Board of Directors.
Enrollment was completed in the SYMPHONY-PE IDE study evaluating the Symphony Thrombectomy System for acute pulmonary embolism.
Imperative Care launched the Zoom DuoPort technology, enabling the Continuous Dual Aspiration Technique (CDAT) with two Zoom Aspiration Catheters running simultaneously from a single vacuum source, and announced the first patients treated.
Todd Van Horn was appointed Chief Financial Officer of Imperative Care.
Instylla announced the appointment of Daniel Davis to its Board of Directors.
The company will fund an investigator-initiated randomized trial comparing continuous dual aspiration thrombectomy with the Zoom Stroke System plus best medical treatment versus best medical treatment alone for M2 occlusions.
Kandu Health and Neurolutions merged to form Kandu, Inc., combining brain-computer interface technology with personalized telehealth for stroke recovery, and completed the first close of a $30 million financing co-led by Ally Bridge Group and AMED Ventures.